Publication Cover
Reproductive Health Matters
An international journal on sexual and reproductive health and rights
Volume 16, 2008 - Issue sup31: Second trimester abortion: public policy, women's health
4,240
Views
28
CrossRef citations to date
0
Altmetric
Original Articles

Surgical Abortion in the Second Trimester

Pages 151-161 | Published online: 02 Sep 2008

References

  • C Tietze, S Lewit. Joint program for the study of abortion (JPSA): Early medical complications of legal abortion. Studies in Family Planning. 3(6): 1972; 97–123.
  • W Cates Jr, KF Schulz, DA Grimes. Dilatation and evacuation procedures and second-trimester abortions. The role of physician skill and hospital setting. Journal of American Medical Association. 248(5): 1982; 559–563.
  • Y Manabe, A Nakajima. Laminaria-metreurynter method of midterm abortion in Japan. Obstetrics & Gynecology. 40(4): 1972; 612–614.
  • I Bierer, V Steiner. Termination of pregnancy in the second trimester with the aid of laminaria tents. Medical Gynaecology and Sociology. 6(1): 1972; 9–10.
  • DA Grimes, W Cates Jr. Instrumental abortion in the second trimester: an overview. MJ Keirse, JB Gravenhorst, DA Van Lith, MP Embrey. Second trimester pregnancy termination. 1982; Martinus Nijhoff: The Hague, 65–79.
  • ME Kafrissen, KF Schulz, DA Grimes. Midtrimester abortion. Intra-amniotic instillation of hyperosmolar urea and prostaglandin F2 alpha v dilatation and evacuation. Journal of American Medical Association. 251(7): 1984; 916–919.
  • DA Grimes, KF Schulz, W Cates Jr. Mid-trimester abortion by dilatation and evacuation: a safe and practical alternative. New England Journal of Medicine. 296(20): 1977; 1141–1145.
  • DA Grimes, JF Hulka, ME McCutchen. Midtrimester abortion by dilatation and evacuation versus intra-amniotic instillation of prostaglandin F2 alpha: a randomised clinical trial. American Journal of Obstetrics & Gynecology. 137: 1980; 7.
  • WE Brenner, DA Edelman. Dilatation and evacuation at 13 to 15 weeks' gestation versus intra-amniotic saline after 15 weeks' gestation. Contraception. 10(2): 1974; 171–180.
  • KI Cadesky, E Ravinsky, ER Lyons. Dilation and evacuation: a preferred method of midtrimester abortion. American Journal of Obstetrics & Gynecology. 139(3): 1981; 329–332.
  • AM Altman, PG Stubblefield, JF Schlam. Midtrimester abortion with laminaria and vacuum evacuation on a teaching service. Journal of Reproductive Medicine. 30(8): 1985; 601–606.
  • T Crist, P Williams, SH Lee. Midtrimester pregnancy termination: a study of the cost effectiveness of dilation and evacuation in a free-standing facility. North Carolina Medical Journal. 44(9): 1983; 549–551.
  • OS Tang, PC Ho. Medical abortion in the second trimester. Best Practice & Research Clinical Obstetrics & Gynaecology. 16(2): 2002; 237–246.
  • DR Urquhart, A Templeton. The use of mifepristone prior to prostaglandin-induced mid-trimester abortion. Human Reproduction. 5(7): 1990; 883–886.
  • MW Rodger, DT Baird. Pretreatment with mifepristone (RU-486) reduces interval between prostaglandin administration and expulsion in second trimester abortion. British Journal of Obstetrics and Gynaecology. 97(1): 1990; 41–45.
  • KJ Thong, DT Baird. Induction of second trimester abortion with mifepristone and gemeprost. British Journal of Obstetrics and Gynaecology. 100: 1993; 758–761.
  • Autry AM, Hayes EC, Jacobson GF, et al. A comparison of medical induction and dilation and evacuation for second-trimester abortion. American Journal of Obstetrics and Gynecology 2002 2002/8;187(2):393–97.
  • DA Grimes, SM Smith, AD Witham. Mifepristone and misoprostol versus dilation and evacution for midtrimester abortion: a pilot randomised controlled trial. British Journal of Obstetrics & Gynaecology. 111: 2004; 148–153.
  • LD Elam-Evans, LT Strauss, J Herndon. Abortion surveillance – United States, 2000. Morbidity & Mortality Weekly Report Surveillance Summaries. 52(SS-12): 2003; 1–32.
  • Department of Health. Abortion Statistics, England and Wales: 2007. Statistical Bulletin 2008/1. 2008; Crown: London.
  • WM Haskell, TR Easterling, ES Lichtenberg. Surgical abortion after the first trimester. M Paul, ES Lichtenberg, L Borgatta. A Clinician's Guide to Medical and Surgical Abortion. 1999; Churchill Livingstone: Philadelphia, 123–138.
  • STAKES. Official statistics of Finland. Induced abortions and sterilisations 2005. Statistical Summary; 2006.
  • LD Castleman, KTH Oanh, AG Hyman. Introduction of the dilation and evacuation procedure for second-trimester abortion in Vietnam using manual vacuum aspiration and buccal misoprostol. Contraception. 74(3): 2006; 272–276.
  • Royal College of Obstetricians and Gynaecologists. The Care of Women Requesting Induced Abortion. 2004; RCOG Press: London.
  • KL Eastwood, JE Kacmar, J Steinauer. Abortion training in United States obstetrics and gynecology residency programs. Obstetrics & Gynecology. 108(2): 2006; 303–308.
  • G Roy, R Parvataneni, B Friedman. Abortion training in Canadian obstetrics and gynecology residency programs. Obstetrics & Gynecology. 108(2): 2006; 308–314.
  • J Steinauer, M Silveira, R Lewis. Impact of formal family planning residency training on clinical competence in uterine evacuation techniques. Contraception. 76(5): 2007; 372–376.
  • J Steinauer, U Landy, H Filippone. Predictors of abortion provision among practicing obstetrician–gynecologists: a national survey. American Journal of Obstetrics and Gynecology. 198(1): 2008; 39.
  • LE Ferris, M McMain-Klein, K Iron. Factors influencing the delivery of abortion services in Ontario: a descriptive study. Family Planning Perspectives. 30(3): 1998; 134–138.
  • NB Kaltreider, S Goldsmith, AJ Margolis. The impact of midtrimester abortion techniques on patients and staff. American Journal of Obstetrics & Gynecology. 135(2): 1979; 235–238.
  • JB Rooks, W Cates Jr. Emotional impact of D&E vs. instillation. Family Planning Perspectives. 9(6): 1977; 276–277.
  • RC Henshaw, SA Naji, IT Russell. Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment. British Medical Journal. 307(6906): 1993; 714–717.
  • FL Howie, RC Henshaw, SA Naji. Medical abortion or vacuum aspiration? Two year follow up of a patient preference trial. British Journal of Obstetrics and Gynaecology. 104: 1997; 829–833.
  • GA Burgoine, SD Van Kirk, J Romm. Comparison of perinatal grief after dilation and evacuation or labor induction in second trimester terminations for fetal anomalies. American Journal of Obstetrics and Gynecology. 192(6): 2005; 1928–1932.
  • LP Shulman, FW Ling, CM Meyers. Dilation and evacuation for second-trimester genetic pregnancy termination. Obstetrics & Gynecology. 75(6): 1990; 1037–1040.
  • BA Bernick, DD Ufberg, R Nemiroff. Success rate of cytogenetic analysis at the time of second-trimester dilation and evacuation. American Journal of Obstetrics & Gynecology. 179(4): 1998; 957–961.
  • PG Stubblefield, BH Albrecht, B Koos. A randomized study of 12mm and 15.9mm cannula in midtrimester abortion by laminaria and vacuum curettage. Fertility and Sterility. 29(5): 1978; 512–517.
  • E El Maradny, N Kanayama, A Halim. Biochemical changes in the cervical mucus after application of laminaria tent. Acta Obstetricia et Gynecologica Scandinavica. 75(3): 1996; 203–207.
  • KH Nicolaides, CC Welch, EN Koullapis. Cervical dilatation by lamicel: studies on the mechanism of action. British Journal of Obstetrics & Gynaecology. 90(11): 1983; 1060–1064.
  • DA Grimes, IG Ray, CJ Middleton. Lamicel versus laminaria for cervical dilation before early second-trimester abortion: a randomized clinical trial. Obstetrics & Gynecology. 69(6): 1987; 887–890.
  • EC Wells, JF Hulka. Cervical dilation: a comparison of lamicel and dilapan. American Journal of Obstetrics & Gynecology. 161(5): 1989; 1124–1126.
  • DA Grimes, KF Schulz, W Cates Jr. Prevention of uterine perforation during curettage abortion. Journal of American Medical Association. 251: 1984; 2108–2111.
  • KF Schulz, DA Grimes, W Cates Jr. Measures to prevent cervical injury during suction curettage abortion. Lancet. 8335(1): 1983; 1182–1185.
  • WM Hern. Laminaria versus dilapan osmotic cervical dilators for outpatient dilation and evacuation abortion: randomized cohort comparison of 1001 patients. American Journal of Obstetrics & Gynecology. 171(5): 1994; 1324–1328.
  • CS Todd, M Soler, L Castleman. Buccal misoprostol as cervical preparation for second trimester pregnancy termination. Contraception. 65(6): 2002; 415–418.
  • A Patel, E Talmont, J Morfesis. Adequacy and safety of buccal misoprostol for cervical preparation prior to termination of second-trimester pregnancy. Contraception. 73(4): 2006; 420–430.
  • AB Goldberg, EA Drey, AK Whitaker. Misoprostol compared with laminaria before early second-trimester surgical abortion: a randomized trial. Obstetrics & Gynecology. 106(2): 2005; 234–241.
  • AB Edelman, JG Buckmaster, MF Goetsch. Cervical preparation using laminaria with adjunctive buccal misoprostol before second-trimester dilation and evacuation procedures: a randomized clinical trial. American Journal of Obstetrics & Gynecology. 194: 2006; 425–430.
  • LCY Poon, J Parsons. Audit of the effectiveness of cervical preparation with dilapan prior to late second-trimester (20–24 weeks) surgical termination of pregnancy. BJOG. 114(4): 2007; 485–488.
  • RC Henshaw, AA Templeton. Pre-operative cervical preparation before first trimester vacuum aspiration: a randomized controlled comparison between gemeprost and mifepristone (RU 486). British Journal of Obstetrics & Gynaecology. 98(10): 1991; 1025–1030.
  • PW Ashok, GM Flett, A Templeton. Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: a randomized, controlled study. American Journal of Obstetrics & Gynecolology. 183(4): 2000; 998–1002.
  • JL Carbonell, FG Gallego, MP Llorente. Vaginal vs. sublingual misoprostol with mifepristone for cervical priming in second-trimester abortion by dilation and evacuation: a randomized clinical trial. Contraception. 75(3): 2007; 230–237.
  • ST Chasen, RB Kalish, M Gupta. Dilation and evacuation at >/=20 weeks: comparison of operative techniques. American Journal of Obstetrics and Gynecology. 190(5): 2004; 1180–1183.
  • E Drey, L Thomas, N Benowitz. Safety of intra-amniotic digoxin administration before late second-trimester abortion by dilation and evacuation. American Journal of Obstetrics & Gynecology. 182: 2000; 1063–1066.
  • L Pasquini, V Pontello, S Kumar. Intracardiac injection of potassium chloride as method for feticide: experience from a single UK tertiary centre. BJOG. 115(4): 2008; 528–531.
  • M Molaei, HE Jones, T Weiselberg. Effectiveness and safety of digoxin to induce fetal demise prior to second-trimester abortion. Contraception. 77(3): 2008; 223–225.
  • WM Hern. Laminaria, induced fetal demise and misoprostol in late abortion. International Journal of Gynecology & Obstetrics. 75: 2001; 279–286.
  • WM Hern, C Zen, KA Ferguson. Outpatient abortion for fetal anomaly and fetal death from 15–34 menstrual weeks' gestation: techniques and clinical management. Obstetrics & Gynecology. 81: 1993; 301–306.
  • RA Jackson, VL Teplin, EA Drey. Digoxin to facilitate late second-trimester abortion: a randomized, masked, placebo-controlled trial. Obstetrics & Gynecology. 97: 2001; 471–476.
  • WF Peterson, FN Berry, MR Grace. Second-trimester abortion by dilatation and evacuation: an analysis of 11,747 cases. Obstetrics & Gynecology. 62(2): 1983; 185–190.
  • ME Kafrissen, MW Barke, P Workman. Coagulopathy and induced abortion method, rates and relative risks. American Journal of Obstetrics & Gynecology. 147: 1983; 344–345.
  • G Woodward. Intraoperative blood loss in midtrimester dilatation and extraction. Obstetrics & Gynecology. 62(1): 1983; 69–72.
  • KF Schulz, DA Grimes, DD Christensen. Vasopressin reduces blood loss from second-trimester dilatation and evacuation abortion. Lancet. 2: 1985; 353–356.
  • BR Pridmore, DG Chambers. Uterine perforation during surgical abortion: a review of diagnosis, management and prevention. Australian & New Zealand Journal of Obstetrics and Gynaecology. 39(9): 1999; 349–353.
  • PD Darney, RL Sweet. Routine intraoperative ultrasonography for second trimester abortion reduces incidence of uterine perforation. Journal of Ultrasound in Medicine. 8(2): 1989; 71–75.
  • PD Darney, E Atkinson, K Hirabayashi. Uterine perforation during second-trimester abortion by cervical dilation and instrumental extraction: a review of 15 cases. Obstetrics & Gynecology. 73(3): 1990; 441–444.
  • TL Baird, LD Castleman, G Alyson. Clinician's Guide for Second-Trimester Abortion. 2nd ed., 2007; Ipas: Chapel Hill NC.
  • FR Jacot, C Poulin, AP Bilodeau. A five-year experience with second-trimester induced abortions: no increase in complication rate as compared to the first trimester. American Journal of Obstetrics & Gynecology. 168(2): 1993; 633–637.
  • ST Chasen, RB Kalish, M Gupta. Obstetric outcomes after surgical abortion at >/= 20 weeks' gestation. American Journal of Obstetrics and Gynecology. 193(3): 2005; 1161–1164.
  • RB Kalish, ST Chasen, LB Rosenzweig. Impact of midtrimester dilation and evacuation on subsequent pregnancy outcome. American Journal of Obstetrics and Gynecology. 187(4): 2002; 882–885.
  • JE Jackson, WA Grobman, E Haney. Mid-trimester dilation and evacuation with laminaria does not increase the risk for severe subsequent pregnancy complications. International Journal of Gynecology and Obstetrics. 96(1): 2007; 12–15.
  • HT MacKay, KF Schulz, DA Grimes. Safety of local versus general anesthesia for second-trimester dilatation and evacuation abortion. Obstetrics & Gynecology. 66(5): 1985; 661–665.
  • E Hakim-Elahi, HMM Tovell, MS Burnhill. Complications of first trimester abortion: a report of 170,000 cases. Obstetrics & Gynecology. 76: 1990; 129–135.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.